BioCentury
ARTICLE | Financial News

NovaQuest closes $459 million third fund

November 1, 2013 1:02 AM UTC

NovaQuest Capital Management closed its NovaQuest Pharma Opportunities Fund III at $459 million. NovaQuest invests in late-stage and commercial biopharmaceutical companies. The firm's active portfolio...